Sales Specialist
Location
Kentucky + 2 moreAll locations: Kentucky, North Carolina, Tennessee
Posted
1 day ago
Salary
$119K - $138K / year
Job Description
Job Requirements
- Bachelor of Arts or Bachelor of Science OR equivalent work experience
- Minimum 3+ years relevant sales (or equivalent experience)
- Prior capital sales experience
- Experience with Salesforce.com or other CRM software
- Experience with Microsoft Office including Word, Excel, PowerPoint and Outlook
- Ability to travel – 50-75% overnight
- Must have a valid driver’s license with an acceptable driving record
- Ability to lift, move or carry equipment up to 50lb
- Ability to walk, sit, stand, use hand to finger, handle or feel objects, tools, or controls; reach with hands and arms; balance, stoop, bend, talk and hear
- Specific vision abilities required by the job include close vision, distance vision, color vision, peripheral vision, depth perception, and the ability to adjust focus.
Benefits
- Health insurance
- 401(k)
- Paid time off
- Flexible work arrangements
- Bonuses
Related Guides
Related Job Pages
More Sales Jobs
Senior/Advanced Lung Disease Sales Specialist (Albany, NY) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and/or IPF patients. This involves building professional relationships with various customer types, analyzing sales reports to develop business plans, and ensuring maximal product messaging and education.
Senior/Advanced Lung Disease Sales Specialist (North Boston, MA) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and IPF patients. This involves building professional relationships with various customer types, analyzing sales reports to develop business plans, and ensuring maximal product messaging and education.
Senior/Advanced Lung Disease Sales Specialist (South Boston, MA) *Rare Disease Opportunity*
United Therapeutics CorporationWe are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Advanced Lung Disease Specialist is responsible for maintaining and increasing sales of all UT products, primarily Tyvaso, within a defined territory by executing sales and marketing strategies and serving as an educational resource for healthcare professionals treating PH-ILD and IPF patients. This involves building professional relationships with various customer types, analyzing sales reports to develop business plans, and ensuring maximal product messaging and education.
This role involves providing technical and clinical support during surgeries and implants of Cardiac Rhythm Management (CRM) devices, alongside educating healthcare professionals on product use and therapies. The associate will also complete sales training, manage necessary documentation, update sales representatives, and handle inventory management for assigned accounts.
